• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Gryphon-Backed Water’s Edge Dermatology Acquires PBC Dermatology

Share:

May 6, 2019

Water’s Edge Dermatology, a leading provider of comprehensive dermatology services through 35 Florida locations, announced today it has acquired a controlling interest in PBC Dermatology, a medical / surgical dermatology practice in West Palm Beach, Florida. Terms of the transaction were not disclosed.

This transaction is the first add-on acquisition for Water’s Edge since it was acquired by San Francisco-based middle-market private equity firm Gryphon Investors in June 2018.

“The demand for dermatological services continues to increase, driven by a steadily aging population, increasing rates of skin cancer, and the appeal of affordable, convenient cosmetic procedures,” said Gryphon Healthcare Operating Partner Kevin Blank. “Water’s Edge will continue to seek out high-quality practices that can help meet that demand, and we are pleased to partner with the highly-regarded West Palm Beach-based PBC Dermatology.”

PBC (www.pbcdermatology.com) is a long-standing West Palm Beach area practice founded by Charles E. Griff, MD. The practice offers general medical dermatology services, Mohs surgery, and various cosmetic procedures. Dr. Griff will have an equity interest in the Company and continue as a leader of the practice post-close.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Water’s Edge thrives by putting patients first and offering them access to cutting-edge procedures that produce optimal outcomes,” said Dr. Ted Schiff, Chief Medical Officer at Water’s Edge. “Dr. Griff and his team clearly share our vision, and their well-respected reputation in our local market is a benefit for new and existing patients.”

Larry Kraska, Water’s Edge CEO, commented, “Our growth plan calls for adding new practices that meet our high standards of integrity and medical proficiency. Adding PBC under the Water’s Edge umbrella will allow us to expand our service offerings in the Palm Beach area. We aim to attract additional top dermatologists and clinicians as we build a premier system of care that can manage the complex operational, technological, financial, and regulatory requirements necessary to operate in dermatology today.”

Dr. Griff added, “We are delighted to be partnering with Water’s Edge to fuel our growth. They share our values, including high clinical standards and a commitment to putting our patients first. We look forward to the rewards this combination will bring to our patients and our staff.”

Date: May 06, 2019

Source: Yahoo Finance

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Regenacy Pharma Earns $30 Million Series A to Advance Diabetic Neuropathy DrugRegenacy Pharma Earns $30 Million Series A to Advance Diabetic Neuropathy Drug
  • Afya Limited Announces Cliquefarma’s AcquisitionAfya Limited Announces Cliquefarma’s Acquisition
  • Atlas Lift Tech Expands to the Arizona Market with the launch of Abrazo Facilities on November 26thAtlas Lift Tech Expands to the Arizona Market with the launch of Abrazo Facilities on November 26th
  • Curebase Teams up with AppliedVR on Pain Treatment and Other Digital Health DealsCurebase Teams up with AppliedVR on Pain Treatment and Other Digital Health Deals
  • DOC2US’ Telemedicine Services Now Accessible By AIA Malaysia’s CustomersDOC2US’ Telemedicine Services Now Accessible By AIA Malaysia’s Customers
  • Accelus Announces Closing of $20 Million Debt Facility with Symbiotic CapitalAccelus Announces Closing of $20 Million Debt Facility with Symbiotic Capital
  • XNK Therapeutics receives funding from Sweden’s innovation agency VinnovaXNK Therapeutics receives funding from Sweden’s innovation agency Vinnova
  • Insights on the Bioanalytical Testing Services Global Market to 2030 – Expansion of Bioanalytical Testing Facilities is Driving GrowthInsights on the Bioanalytical Testing Services Global Market to 2030 – Expansion of Bioanalytical Testing Facilities is Driving Growth

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications